Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [1] Hyperacute stroke therapy with tissue plasminogen activator
    Alberts, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (4C): : D29 - D34
  • [2] INTRAVENOUS TISSUE-PLASMINOGEN ACTIVATOR AMELIORATES THE OUTCOME OF HYPERACUTE EMBOLIC STROKE
    YAMAGUCHI, T
    HAYAKAWA, T
    KIUCHI, H
    CEREBROVASCULAR DISEASES, 1993, 3 (04) : 269 - 272
  • [3] Early Changes of Tissue Perfusion After Tissue Plasminogen Activator in Hyperacute Ischemic Stroke
    An, Hongyu
    Ford, Andria L.
    Vo, Katie
    Eldeniz, Cihat
    Ponisio, Rosana
    Zhu, Hongtu
    Li, Yimei
    Chen, Yasheng
    Powers, William J.
    Lee, Jin-Moo
    Lin, Weili
    STROKE, 2011, 42 (01) : 65 - 72
  • [4] Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic stroke - Does everyone need it?
    Aiyagari, V
    Gujjar, A
    Zazulia, AR
    Diringer, MN
    STROKE, 2004, 35 (10) : 2326 - 2330
  • [5] Outcomes of intravenous tissue plasminogen activator administration for acute stroke in nonagenarians
    Mateen, Farrah J.
    Spencer, Byron R.
    Freeman, William D.
    Demaerschalk, Bart M.
    Zubkov, Alexander Y.
    Wijdicks, Eelco F. M.
    ANNALS OF NEUROLOGY, 2008, 64 : S16 - S17
  • [6] Outcomes of Intravenous Tissue Plasminogen Activator Use in Octogenarians with Ischemic Stroke
    Campos, Yesica
    Sanchez, Sebastian
    Deprince, Maureen
    Vibbert, Matthew
    Urtecho, Jacqueline
    Athar, M. Kamran
    Bar, Barak
    Tzeng, Diana
    Sheehan, Lori
    Pineda, Carissa
    Bell, Rodney
    Tjoumakaris, Stavropoula
    Jabbour, Pascal
    Rosenwasser, Robert
    Rincon, Fred
    NEUROLOGY, 2016, 86
  • [7] Intravenous tissue plasminogen activator and stroke in the elderly
    Longstreth, W. T., Jr.
    Katz, Ronit
    Tirschwell, David L.
    Cushman, Mary
    Psaty, Bruce M.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (03): : 359 - 363
  • [8] Decompressive craniectomy after intravenous tissue plasminogen activator administration for stroke
    Takeuchi, Satoru
    Wada, Kojiro
    Nawashiro, Hiroshi
    Arimoto, Hirohiko
    Ohkawa, Hidenori
    Masaoka, Hiroyuki
    Otani, Naoki
    Takasato, Yoshio
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (10) : 1312 - 1315
  • [9] Decrease in Blood Pressure After Intravenous Administration of Urapidil During Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke
    Bugnicourt, Jean-Marc
    Duru, Cecile
    Picard, Candice
    Godefroy, Olivier
    CLINICAL THERAPEUTICS, 2008, 30 (09) : 1675 - 1680
  • [10] Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients
    Lee, Min-Hyung
    Im, Sang-Hyuk
    Jo, Kwang Wook
    Yoo, Do-Sung
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2023, 66 (02) : 144 - 154